ESMO Guidance for Reporting Oncology real-World evidence (GROW)

作     者：Castelo-Branco, L. Pellat, A. Martins-Branco, D. Valachis, A. Derksen, J.W.G. Suijkerbuijk, K.P.M. Dafni, U. Dellaporta, T. Vogel, A. Prelaj, A. Groenwold, R.H.H. Martins, H. Stahel, R. Bliss, J. Kather, J. Ribelles, N. Perrone, F. Hall, P.S. Dienstmann, R. Booth, C.M. Pentheroudakis, G. Delaloge, S. Koopman, M. 

作者机构：Scientific and Medical Division European Society for Medical Oncology (ESMO) Lugano Switzerland Department of Gastroenterology and Digestive Oncology Hôpital Cochin AP-HP Université Paris Cité Paris Centre d’Épidémiologie Clinique Hôtel Dieu Paris France Université Libre de Bruxelles (ULB) Hôpital Universitaire de Bruxelles (HUB) Institut Jules Bordet Academic Trials Promoting Team (ATPT) Brussels Belgium Department of Oncology Faculty of Medicine and Health Örebro University Hospital Örebro University Örebro Sweden Julius Center for Health Sciences and Primary Care Department of Epidemiology and Health Economics University Medical Centre Utrecht Utrecht University Utrecht Department of Medical Oncology University Medical Centre Utrecht Utrecht University Utrecht The Netherlands Laboratory of Biostatistics Department of Nursing National and Kapodistrian University of Athens Athens Frontier Science Foundation Hellas Athens Greece Department of Gastroenterology Hepatology and Endocrinology Medical School of Hannover Hannover Germany Toronto Center of Liver Disease Toronto General Hospital University Health Network Toronto Princess Margaret Cancer Centre University of Toronto Toronto Canada AI-ON-Lab Medical Oncology Department Fondazione IRCCS Istituto Nazionale Tumori Milan NEARLab Department of Electronics Information and Bioengineering Politecnico di Milano Milan Italy Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands Business Research Unit ISCTE Business School ISCTE-IUL Lisbon Portugal ETOP IBCSG Partners Foundation Bern Switzerland ICR-CTSU Division of Clinical Studies The Institute of Cancer Research London UK Else Kroener Fresenius Center for Digital Health Technical University Dresden Dresden Medical Oncology National Center for Tumor Diseases University Hospital Heidelberg Heidelberg Germany Medical Oncology Intercenter Unit Regional and Virgen de la Victoria University Hospitals IBIMA Málaga Spain Clinical Trial Unit Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples Italy Institute of Genetics and Cancer University of Edinburgh Edinburgh UK Oncoclinicas Precision Medicine Oncoclinicas Group São Paulo Brazil Oncology Data Science Group Vall d’Hebron Institute of Oncology Barcelona Spain Department of Oncology Department of Public Health Sciences Queen’s University Kingston Canada 

出 版 物：《ESMO Real World Data and Digital Oncology》 

年 卷 期：2023年第1卷

页      面：100003-100003页

主　　题：ESMO-GROW guidance observational studies oncology real-world data real-world evidence 

摘      要：Highlights•Real-world evidence in oncology is evolving rapidly with many particularities. •This guidance provides key recommendations for reporting real-world evidence studies in oncology. •Recommendations are based on a review of current evidence and the authors’ collective expert opinion. •Authors are a multidisciplinary group of experts from different institutions and countries. •Guidance is provided for full article development, including title, introduction, methods, results, discussion, conclusion.